GeneDx Holdings (WGS) Current Leases (2020 - 2021)

GeneDx Holdings (WGS) reported Current Leases of $3.4 million for Q4 2021, down 2.48% year-over-year from $3.5 million in Q4 2020, and down 2.48% quarter-over-quarter from $3.5 million in Q4 2020.

GeneDx Holdings (WGS) Current Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has 2 years of Current Leases data on file, last reported at $3.4 million in Q4 2021.

  • Current Leases for Q4 2021 came in at $3.4 million, down 2.48% year-over-year; the trailing twelve-month figure through Dec 2021 was $3.4 million (down 2.48% YoY), and the FY2021 annual result was $3.4 million, down 2.48% from the prior year.
  • Current Leases declined to $3.4 million in Q4 2021 per WGS's latest filing, from $3.5 million in the prior quarter.
  • Over five years, Current Leases peaked at $3.5 million in Q4 2020 and troughed at $3.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 53.00 Mn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn -
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn -
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn -
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn -
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn -
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn -
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn -
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn -
10 GeneDx Holdings 1.52 Bn 1.35 Bn 68.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 3.42 Mn
Dec 31, 2020 3.51 Mn